Engaging in Administrative Payment Tasks May Correlate With Treatment Delays and Nonadherence in Cancer Care
PHILADELPHIA – Engaging in administrative tasks to estimate costs or pay for care among a cohort of cancer patients...
Search/Filter
Loading...
Call for Submissions: 2024 AACR June L. Biedler Prize for Cancer Journalism
Awardees will receive $5,000 unrestricted cash prize PHILADELPHIA – The American Association for Cancer Research (AACR) is inviting journalists...
Lorazepam Treatment May Be Linked to Worse Outcomes for Pancreatic Cancer Patients
PHILADELPHIA – Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer...
Electrical Signals Between Skin Cells May Influence Melanoma Initiation
PHILADELPHIA – The transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered...
Four New Institutions Join AACR Project GENIE® Consortium
PHILADELPHIA — To further its commitment to diversity, equity, and inclusion, the American Association for Cancer Research (AACR) has...
AACR Journal Highlights Industry and Regulatory Perspectives on Improving Diversity in Clinical Trials
Article provides timely information following new law that will require trial sponsors to submit Diversity Action Plans to FDA...
Fixed-duration Ibrutinib Plus Venetoclax May Benefit Patients with High-risk Chronic Lymphocytic Leukemia
PHILADELPHIA – First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic...
AACR Congratulates Monica M. Bertagnolli, MD, on Her Nomination as Director of the National Institutes of Health
Bertagnolli would be the second woman to head the NIH PHILADELPHIA – The American Association for Cancer Research (AACR)...
Brain Metastases in Patients with Kidney Cancer May Have Immune-suppressive Tumor Microenvironments
Researchers applied single-nucleus RNA sequencing and spatial transcriptomics to identify potential therapeutic targets in brain metastases ORLANDO, Fla. –...
Olaparib Plus Ceralasertib May Benefit Pediatric Cancer Patients With DNA Repair-deficient Tumors
ORLANDO, Fla. – A combination of the PARP inhibitor olaparib (Lynparza) and the investigational ATR inhibitor ceralasertib showed clinical...